X4 Pharmaceuticals Stock Market Outlook
| XFOR Stock | USD 3.56 0.10 2.73% |
Slightly above 62% of X4 Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding X4 Pharmaceuticals suggests that many traders are alarmed. X4 Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in X4 Pharmaceuticals. Many technical investors use X4 Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use X4 Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward X4 Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding X4 Pharmaceuticals is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell X4 Pharmaceuticals within the specified time frame.
Execute X4 Pharmaceuticals Advice
The XFOR recommendation should be used to complement the investment advice compiled from the current analysts' consensus on X4 Pharmaceuticals. Macroaxis does not own or have any residual interests in X4 Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute X4 Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
For the selected time horizon X4 Pharmaceuticals has a Mean Deviation of 3.08, Semi Deviation of 3.65, Standard Deviation of 4.57, Variance of 20.84, Downside Variance of 15.71 and Semi Variance of 13.33We provide trade recommendation to complement the latest expert consensus on X4 Pharmaceuticals. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at this moment. To make sure X4 Pharmaceuticals is not overpriced, please check out all X4 Pharmaceuticals fundamentals, including its shares owned by institutions, current ratio, net asset, as well as the relationship between the ebitda and number of employees . Given that X4 Pharmaceuticals has a number of shares shorted of 3.09 M, we strongly advise you to confirm X4 Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself this quarter and beyond given your latest risk tolerance and investing horizon.
X4 Pharmaceuticals Trading Alerts and Improvement Suggestions
| X4 Pharmaceuticals had very high historical volatility over the last 90 days | |
| X4 Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.56 M. Net Loss for the year was (37.45 M) with profit before overhead, payroll, taxes, and interest of 28.28 M. | |
| X4 Pharmaceuticals currently holds about 47.38 M in cash with (130.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69. | |
| X4 Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
X4 Pharmaceuticals Returns Distribution Density
The distribution of X4 Pharmaceuticals' historical returns is an attempt to chart the uncertainty of X4 Pharmaceuticals' future price movements. The chart of the probability distribution of X4 Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use X4 Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of X4 Pharmaceuticals returns is essential to provide solid investment analysis for X4 Pharmaceuticals.
| Mean Return | 0.07 | Value At Risk | -4.94 | Potential Upside | 7.57 | Standard Deviation | 4.57 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of X4 Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
X4 Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to X4 Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that X4 Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a XFOR stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.0027 | |
β | Beta against Dow Jones | 0.77 | |
σ | Overall volatility | 4.57 | |
Ir | Information ratio | -0.0047 |
X4 Pharmaceuticals Volatility Alert
X4 Pharmaceuticals shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure X4 Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact X4 Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.X4 Pharmaceuticals Fundamentals Vs Peers
Comparing X4 Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze X4 Pharmaceuticals' direct or indirect competition across all of the common fundamentals between X4 Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as X4 Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of X4 Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing X4 Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare X4 Pharmaceuticals to competition |
| Fundamentals | X4 Pharmaceuticals | Peer Average |
| Return On Equity | -1.57 | -0.31 |
| Return On Asset | -0.34 | -0.14 |
| Profit Margin | (2.80) % | (1.27) % |
| Operating Margin | (12.81) % | (5.51) % |
| Current Valuation | 266.44 M | 16.62 B |
| Shares Outstanding | 87.44 M | 571.82 M |
| Shares Owned By Insiders | 1.15 % | 10.09 % |
| Shares Owned By Institutions | 41.75 % | 39.21 % |
| Number Of Shares Shorted | 3.09 M | 4.71 M |
| Price To Book | 5.05 X | 9.51 X |
| Price To Sales | 9.16 X | 11.42 X |
| Revenue | 2.56 M | 9.43 B |
| Gross Profit | 28.28 M | 27.38 B |
| EBITDA | (27.58 M) | 3.9 B |
| Net Income | (37.45 M) | 570.98 M |
| Cash And Equivalents | 47.38 M | 2.7 B |
| Cash Per Share | 0.69 X | 5.01 X |
| Total Debt | 78.09 M | 5.32 B |
| Debt To Equity | 1.28 % | 48.70 % |
| Current Ratio | 2.39 X | 2.16 X |
| Book Value Per Share | 2.45 X | 1.93 K |
| Cash Flow From Operations | (130.9 M) | 971.22 M |
| Short Ratio | 4.21 X | 4.00 X |
| Earnings Per Share | (8.92) X | 3.12 X |
| Target Price | 8.0 | |
| Number Of Employees | 143 | 18.84 K |
| Beta | 0.43 | -0.15 |
| Market Capitalization | 311.27 M | 19.03 B |
| Total Asset | 146.45 M | 29.47 B |
| Retained Earnings | (515.36 M) | 9.33 B |
| Working Capital | 79.3 M | 1.48 B |
| Net Asset | 146.45 M |
Note: Acquisition by Bridger Gary of 110000 shares of X4 Pharmaceuticals at 4.0 subject to Rule 16b-3 [view details]
X4 Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as XFOR . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About X4 Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell X4 Pharmaceuticals? Buying financial instruments such as XFOR Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having X4 Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for XFOR Stock Analysis
When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.